Agios to receive $1.1B in milestone payments for vorasidenib approval (NASDAQ:AGIO)
study Agios PharmaceuticalsNASDAQ: AGIWAmerican drugmaker ABM said it will receive $1.1 billion in milestone payments after the U.S. Food and Drug Administration approved its drug furasidinib to treat malignant brain tumors. The biotech…
